ONCOLYTICS BIOTECH INC. Basic Shares Outstanding (Weighted Average)
ONCOLYTICS BIOTECH INC. (ONCY) reported Basic Shares Outstanding (Weighted Average) of 119.74 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 119.74M shares, a 31.58% increase year-over-year.
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 112.29M shares, a 32.68% increase year-over-year.
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 91.00M shares.
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 84.63M shares.
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for fiscal 2025 was 95.86M shares, a 25.33% increase from fiscal 2024.
- ONCOLYTICS BIOTECH INC. weighted average number of shares outstanding, basic for fiscal 2024 was 76.48M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | 119.74M shares 10-Q · filed 2026-08-12 | 116.04M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 112.29M shares 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | 95.86M shares 10-K · filed 2026-03-30 | ||
| 2025-06-30 | 91.00M shares 10-Q · filed 2026-08-12 | 87.83M shares 10-Q · filed 2026-08-12 | |
| 2025-03-31 | 84.63M shares 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | 76.48M shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |